Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In idiopathic pulmonary fibrosis, the quantitation of disease severity using pulmonary function tests is often confounded by emphysema. We have identified the composite physiologic index (CPI) most closely reflecting the morphologic extent of pulmonary fibrosis. Consecutive patients with a clinical/computed tomography (CT) diagnosis of idiopathic pulmonary fibrosis (n = 212) were divided into group I (n = 106) and group II (n = 106). The CPI was derived in group I (by fitting pulmonary function tests against disease extent on CT) and was tested in Group II. The formula for the CPI was as follows: extent of disease on CT = 91.0 − (0.65 × percent predicted diffusing capacity for carbon monoxide [DLCO]) − (0.53 × percent predicted FVC) + (0.34 × percent predicted FEV1). In group II, the CPI correlated more strongly with disease extent on CT (r2 = 0.51) than the individual pulmonary function test (DLCO the highest value, r2 = 0.38). A subanalysis demonstrated that the better fit of the CPI was ascribable to a correction of the confounding effects of emphysema. Mortality was predicted more accurately by the CPI than by a pulmonary function test in all clinical subgroups, including a separate cohort of 36 patients with histologically proven usual interstitial pneumonia (CPI, p < 0.0005; FVC, p = 0.002; PO2, p = 0.002). In conclusion, a new CPI, derived against CT and validated using split sample testing, is a more accurate prognostic determinant in usual interstitial pneumonia than an individual pulmonary function test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the Composite Physiologic Index (CPI) and the Gender-Age-Physiology (GAP) index have been most commonly applied for estimating the survival of patients with IPF [3–6].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
In the citing paper
“CPI quantifies pulmonary function impairment due to pulmonary fibrosis, which is then correlated with the extent of fibrosis in computed tomography while excluding emphysema [3].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Austin, J. H., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Remy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Self-citationHistopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, K. R., TRAVIS, W. D., COLBY, T. V., TOEWS, G. B., KAZEROONI, E. A., GROSS, B. H., JAIN, A., STRAWDERMAN, R. L., FLINT, A., LYNCH, J. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103074 · Cited by 665
Self-citationIdeal Alveolar Air and the Analysis of Ventilation-Perfusion Relationships in the Lungs
Riley, R. L., & Cournand, A. (1949) · Journal of Applied Physiology · doi:10.1152/jappl.1949.1.12.825 · Cited by 563
Travis, W. D., Matsui, K., Moss, J., & Ferrans, V. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00003 · Cited by 530
NICHOLSON, A. G., COLBY, T. V., DUBOIS, R. M., HANSELL, D. M., & WELLS, A. U. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003049 · Cited by 489
Self-citationIdiopathic Pulmonary Fibrosis: Predicting Response to Therapy and Survival
GAY, S. E., KAZEROONI, E. A., TOEWS, G. B., LYNCH, J. P., GROSS, B. H., CASCADE, P. N., SPIZARNY, D. L., FLINT, A., ANTHONY SCHORK, M., WHYTE, R. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9703022 · Cited by 406
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz, D. A., Helmers, R. A., Galvin, J. R., Van Fossen, D. S., Frees, K. L., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306044 · Cited by 340
Research works printed but not linked: 7
- 1995, Am J Respir Crit Care Med, 151, 1180
- 1997, Arthritis Rheum, 40, 1229
- 1983, Clin Respir Physiol, 19, 1
- 1994, Am J Respir Crit Care Med, 149, 450, 10.1164/ajrccm.149.2.8306044 · DOI · Paper page
- 1983, Am Rev Respir Diagn, 2, 43
- 1976, Chest, 69, 263
- 1995, Am J Respir Crit Care Med, 151, 1180
Cited by
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationInterpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
“A composite physiologic index has been developed that may account for emphysema in IPF combining FVC, DLCO, and FEV1 into a formula that correlates better with disease extent by CT than any individual pulmonary function test and may be a more accurate predictor of survival (95, 96).”
BackgroundPrednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Self-citationA Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Ley, B., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Tomassetti, S., Lee, J. S., Poletti, V., Buccioli, M., Elicker, B. M., Jones, K. D., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00004 · Cited by 1,308
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Self-citationBUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends
Latsi, P. I., du Bois, R. M., Nicholson, A. G., Colby, T. V., Bisirtzoglou, D., Nikolakopoulou, A., Veeraraghavan, S., Hansell, D. M., & Wells, A. U. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1245oc · Cited by 583
“However, changes in other indices at 1 year, including the recently described CPI (23), were also substantially more predictive of outcome than the histopathologic diagnosis.”
InfluentialSelf-citationPredicting Survival Across Chronic Interstitial Lung Disease
Ryerson, C. J., Vittinghoff, E., Ley, B., Lee, J. S., Mooney, J. J., Jones, K. D., Elicker, B. M., Wolters, P. J., Koth, L. L., King, T. E., et al. (2014) · Chest · doi:10.1378/chest.13-1474 · Cited by 558
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationRandomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401739 · Cited by 505
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Lancaster, L., de Andrade, J. A., Stähler, G., Leconte, I., Roux, S., & Raghu, G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-732oc · Cited by 500
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis
Sève, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., Valeyre, D., et al. (2021) · Cells · doi:10.3390/cells10040766 · Cited by 487
“CPI is also more correlated to disease extent than FVC because of DLCO implementation in the calculated index.”
BackgroundInfluentialComorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Raghu, G., Amatto, V. C., Behr, J., & Stowasser, S. (2015) · European Respiratory Journal · doi:10.1183/13993003.02316-2014 · Cited by 463
Peljto, A. L., Zhang, Y., Fingerlin, T. E., Ma, S.-F., Garcia, J. G. N., Richards, T. J., Silveira, L. J., Lindell, K. O., Steele, M. P., Loyd, J. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.5827 · Cited by 453
Classification and Natural History of the Idiopathic Interstitial Pneumonias
Kim, D. S., Collard, H. R., & King, T. E. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-005tk · Cited by 431
Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
du Bois, R. M., Weycker, D., Albera, C., Bradford, W. Z., Costabel, U., Kartashov, A., Lancaster, L., Noble, P. W., Raghu, G., Sahn, S. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1790oc · Cited by 424
“Two clinical prediction models have been developed for patients with IPF (4, 5).”
BackgroundMethodResultMeltzer, E. B., & Noble, P. W. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-8 · Cited by 407
“34 percent predicted FEV1), and has been shown to reflect the extent of disease more accurately than single physiologic indices [38].”
Agarwala, P., & Salzman, S. H. (2020) · Chest · doi:10.1016/j.chest.2019.10.014 · Cited by 394
Hamada, K., Nagai, S., Tanaka, S., Handa, T., Shigematsu, M., Nagao, T., Mishima, M., Kitaichi, M., & Izumi, T. (2007) · Chest · doi:10.1378/chest.06-1466 · Cited by 390
Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
Solomon, J. J., Chung, J. H., Cosgrove, G. P., Demoruelle, M. K., Fernandez-Perez, E. R., Fischer, A., Frankel, S. K., Hobbs, S. B., Huie, T. J., Ketzer, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00357-2015 · Cited by 388
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., Li, K., Choi, J., Vuga, L. J., Lindell, K. O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0058oc · Cited by 381
“The proportional hazards model was used to adjust for age, sex, and baseline pulmonary function assessed by FVC or composite physiologic index (CPI) (28).”
MethodInfluentialZappala, C. J., Latsi, P. I., Nicholson, A. G., Colby, T. V., Cramer, D., Renzoni, E. A., Hansell, D. M., du Bois, R. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00155108 · Cited by 372
Self-citationIdiopathic pulmonary fibrosis: state of the art for 2023
Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359
Goh, N. S., Hoyles, R. K., Denton, C. P., Hansell, D. M., Renzoni, E. A., Maher, T. M., Nicholson, A. G., & Wells, A. U. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40130 · Cited by 354
Self-citationCombined Pulmonary Fibrosis and Emphysema Syndrome
Jankowich, M. D., & Rounds, S. I. S. (2012) · Chest · doi:10.1378/chest.11-1062 · Cited by 333
Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases
King, T. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-483oe · Cited by 330
“Predictor models based on combining multiple baseline clinical, radiologic, or physiologic measurements have been derived from large groups of carefully selected patients with IPF and appear to perform well as predictors of outcome (60, 61).”
MethodRyerson, C. J., Hartman, T., Elicker, B. M., Ley, B., Lee, J. S., Abbritti, M., Jones, K. D., King, T. E., Ryu, J., & Collard, H. R. (2013) · Chest · doi:10.1378/chest.12-2403 · Cited by 315
Jenkins, R. G., Simpson, J. K., Saini, G., Bentley, J. H., Russell, A.-M., Braybrooke, R., Molyneaux, P. L., McKeever, T. M., Wells, A. U., Flynn, A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00048-x · Cited by 314
Self-citationPrevalence and prognosis of unclassifiable interstitial lung disease
Ryerson, C. J., Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131912 · Cited by 310
“[6, 7] The Composite Physiologic Index (CPI) was calculated as previously reported.[8] Follow-up FVC and DLCO were collected at 12 (+/– 3) months when available.”
MethodJacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M., Nair, A., Karwoski, R., Walsh, S. L. F., Wells, A. U., & Hansell, D. M. (2017) · European Respiratory Journal · doi:10.1183/13993003.01011-2016 · Cited by 309
“One of these was the CPI, and the finding confirms previous reports highlighting the strength of signal of the CPI in predicting outcome in fibrosing lung disease [22, 23].”
ResultSelf-citationPhysiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
Jegal, Y., Kim, D. S., Shim, T. S., Lim, C.-M., Do Lee, S., Koh, Y., Kim, W. S., Kim, W. D., Lee, J. S., Travis, W. D., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-331oc · Cited by 308
Self-citationSato, T., Teramukai, S., Kondo, H., Watanabe, A., Ebina, M., Kishi, K., Fujii, Y., Mitsudomi, T., Yoshimura, M., Maniwa, T., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.09.050 · Cited by 307
Baseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis
Kinder, B. W., Brown, K. K., Schwarz, M. I., Ix, J. H., Kervitsky, A., & King, T. E. (2008) · Chest · doi:10.1378/chest.07-1948 · Cited by 302
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Raghu, G., Million-Rousseau, R., Morganti, A., Perchenet, L., Behr, J., & the MUSIC Study Group (2013) · European Respiratory Journal · doi:10.1183/09031936.00104612 · Cited by 277
Six-Minute Walk, Maximal Exercise Tests: Reproducibility in Fibrotic Interstitial Pneumonia
Eaton, T., Young, P., Milne, D., & Wells, A. U. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-578oc · Cited by 274
Self-citationPulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis
Nathan, S. D., Shlobin, O. A., Ahmad, S., Urbanek, S., & Barnett, S. D. (2007) · Chest · doi:10.1378/chest.06-2485 · Cited by 270
Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis
Maldonado, F., Moua, T., Rajagopalan, S., Karwoski, R. A., Raghunath, S., Decker, P. A., Hartman, T. E., Bartholmai, B. J., Robb, R. A., & Ryu, J. H. (2014) · European Respiratory Journal · doi:10.1183/09031936.00071812 · Cited by 264
De Lauretis, A., Sestini, P., Pantelidis, P., Hoyles, R., Hansell, D. M., Goh, N. S. L., Zappala, C. J., Visca, D., Maher, T. M., Denton, C. P., et al. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120725 · Cited by 263
Self-citationPhysiology of the lung in idiopathic pulmonary fibrosis
Plantier, L., Cazes, A., Dinh-Xuan, A.-T., Bancal, C., Marchand-Adam, S., & Crestani, B. (2018) · European Respiratory Review · doi:10.1183/16000617.0062-2017 · Cited by 259
Progressive pulmonary fibrosis: an expert group consensus statement
Rajan, S. K., Cottin, V., Dhar, R., Danoff, S., Flaherty, K. R., Brown, K. K., Mohan, A., Renzoni, E., Mohan, M., Udwadia, Z., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.03187-2021 · Cited by 258
Self-citationPredictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease
Winstone, T. A., Assayag, D., Wilcox, P. G., Dunne, J. V., Hague, C. J., Leipsic, J., Collard, H. R., & Ryerson, C. J. (2014) · Chest · doi:10.1378/chest.13-2626 · Cited by 249
du Bois, R. M., Albera, C., Bradford, W. Z., Costabel, U., Leff, J. A., Noble, P. W., Sahn, S. A., Valeyre, D., Weycker, D., & King, T. E. (2014) · European Respiratory Journal · doi:10.1183/09031936.00131813 · Cited by 246
Predictors of mortality in pulmonary sarcoidosis
Kirkil, G., Lower, E. E., & Baughman, R. P. (2018) · Chest · doi:10.1016/j.chest.2017.07.008 · Cited by 243
Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
Raghu, G., Collard, H. R., Anstrom, K. J., Flaherty, K. R., Fleming, T. R., King, T. E., Martinez, F. J., & Brown, K. K. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0006pp · Cited by 242
“Other potential surrogate endpoints such as the DLCO and the composite scoring systems have similar limitations (2, 30, 31).”
BackgroundEvans, C. M., Fingerlin, T. E., Schwarz, M. I., Lynch, D., Kurche, J., Warg, L., Yang, I. V., & Schwartz, D. A. (2016) · Physiological Reviews · doi:10.1152/physrev.00004.2016 · Cited by 238
Visca, D., Mori, L., Tsipouri, V., Fleming, S., Firouzi, A., Bonini, M., Pavitt, M. J., Alfieri, V., Canu, S., Bonifazi, M., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30289-3 · Cited by 235
Self-citationJo, H. E., Glaspole, I., Grainge, C., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01592-2016 · Cited by 233
Self-citationAn integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study
Walsh, S. L., Wells, A. U., Sverzellati, N., Keir, G. J., Calandriello, L., Antoniou, K. M., Copley, S. J., Devaraj, A., Maher, T. M., Renzoni, E., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70276-5 · Cited by 232
Self-citationStock, C. J., Sato, H., Fonseca, C., Banya, W. A. S., Molyneaux, P. L., Adamali, H., Russell, A.-M., Denton, C. P., Abraham, D. J., Hansell, D. M., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-201786 · Cited by 231
Self-citationPulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis
Meyer, K. C. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1312346 · Cited by 227
Cottin, V., Selman, M., Inoue, Y., Wong, A. W., Corte, T. J., Flaherty, K. R., Han, M. K., Jacob, J., Johannson, K. A., Kitaichi, M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1041st · Cited by 226
Self-citationBosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
Corte, T. J., Keir, G. J., Dimopoulos, K., Howard, L., Corris, P. A., Parfitt, L., Foley, C., Yanez-Lopez, M., Babalis, D., Marino, P., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0446oc · Cited by 226
Self-citationPredicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Mura, M., Porretta, M. A., Bargagli, E., Sergiacomi, G., Zompatori, M., Sverzellati, N., Taglieri, A., Mezzasalma, F., Rottoli, P., Saltini, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00106011 · Cited by 225
Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
Kinder, B. W., Brown, K. K., McCormack, F. X., Ix, J. H., Kervitsky, A., Schwarz, M. I., & King, T. E. (2009) · Chest · doi:10.1378/chest.08-2209 · Cited by 209
Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease
Cottin, V., Nunes, H., Mouthon, L., Gamondes, D., Lazor, R., Hachulla, E., Revel, D., Valeyre, D., Cordier, J., & Pulmonaires, G. D. E. D. R. S. L. M. “. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30077 · Cited by 206
“The composite physiologic index (CPI) was calculated as described by Wells et al (33).”
MethodMacrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Schupp, J. C., Binder, H., Jäger, B., Cillis, G., Zissel, G., Müller-Quernheim, J., & Prasse, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116775 · Cited by 204
“Patients with AE were statistically significantly younger and had worse FVC, DLCO and composite physiologic index (CPI) [25] values compared to IPF patients without AE (Table 1).”
BackgroundInfluentialWhat Every Radiologist Should Know about Idiopathic Interstitial Pneumonias
Mueller-Mang, C., Grosse, C., Schmid, K., Stiebellehner, L., & Bankier, A. A. (2007) · RadioGraphics · doi:10.1148/rg.273065130 · Cited by 202
“The term “microcystic honeycombing” is used for these cystic changes in NSIP, as opposed to the macrocystic honeycombing seen in UIP (32,33).”
BackgroundSignificance of connective tissue disease features in idiopathic interstitial pneumonia
Corte, T. J., Copley, S. J., Desai, S. R., Zappala, C. J., Hansell, D. M., Nicholson, A. G., Colby, T. V., Renzoni, E., Maher, T. M., & Wells, A. U. (2012) · European Respiratory Journal · doi:10.1183/09031936.00174910 · Cited by 199
“The composite physiologic index (CPI) was calculated as previously described [29].”
MethodSelf-citationPulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection
Kumar, P., Goldstraw, P., Yamada, K., Nicholson, A. G., Wells, A. U., Hansell, D. M., duBois, R. M., & Ladas, G. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00028-x · Cited by 197
Self-citationJacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M., Nair, A., Karwoski, R., Raghunath, S. M., Walsh, S. L. F., Wells, A. U., & Hansell, D. M. (2016) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000220 · Cited by 194
Self-citationIdiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status
Antoniou, K. M., Hansell, D. M., Rubens, M. B., Marten, K., Desai, S. R., Siafakas, N. M., Nicholson, A. G., du Bois, R. M., & Wells, A. U. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1759oc · Cited by 191
Self-citationHansell, D. M., Goldin, J. G., King, T. E., Lynch, D. A., Richeldi, L., & Wells, A. U. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00096-x · Cited by 189
Self-citationHumphries, S. M., Yagihashi, K., Huckleberry, J., Rho, B.-H., Schroeder, J. D., Strand, M., Schwarz, M. I., Flaherty, K. R., Kazerooni, E. A., van Beek, E. J. R., et al. (2017) · Radiology · doi:10.1148/radiol.2017161177 · Cited by 188
Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
Alakhras, M., Decker, P. A., Nadrous, H. F., Collazo-Clavell, M., & Ryu, J. H. (2007) · Chest · doi:10.1378/chest.06-2784 · Cited by 186
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis
Lettieri, C. J., Nathan, S. D., Browning, R. F., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.02.004 · Cited by 184
How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard, C., Hilberg, O., & Bendstrup, E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.01.008 · Cited by 180
“Prognostic models in IPF, such as the GAP score [3] or the Composite Physiology Index (CPI) [29], focus on factors directly related to IPF and are strong prognostic determinants.”
MethodQuantitative Computed Tomography Imaging of Interstitial Lung Diseases
Bartholmai, B. J., Raghunath, S., Karwoski, R. A., Moua, T., Rajagopalan, S., Maldonado, F., Decker, P. A., & Robb, R. A. (2013) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e3182a21969 · Cited by 179
Zinellu, A., Collu, C., Nasser, M., Paliogiannis, P., Mellino, S., Zinellu, E., Traclet, J., Ahmad, K., Mangoni, A. A., Carru, C., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184134 · Cited by 193
Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis
Russell, A.-M., Adamali, H., Molyneaux, P. L., Lukey, P. T., Marshall, R. P., Renzoni, E. A., Wells, A. U., & Maher, T. M. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2152oc · Cited by 178
Self-citationStaging of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis
Kishaba, T., Tamaki, H., Shimaoka, Y., Fukuyama, H., & Yamashiro, S. (2014) · Lung · doi:10.1007/s00408-013-9530-0 · Cited by 178
Diagnosis and management of interstitial lung disease
Meyer, K. C. (2014) · Translational Respiratory Medicine · doi:10.1186/2213-0802-2-4 · Cited by 177
“capacity (FVC), diffusion capacity of the lung for carbon monoxide (DLCO), and the 6-minute walk test (6-MWT) distance and oxyhemoglobin saturation change [21-26].”
BackgroundIdiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history
Sgalla, G., Biffi, A., & Richeldi, L. (2016) · Respirology · doi:10.1111/resp.12683 · Cited by 173
Pellegrino, R., Viegi, G., Brusasco, V., Burgos, F., Casaburi, R. H., Coates, A. L., Gustafsson, P., Hankinson, J., Jensen, R. L., MacIntyre, N. R., et al. (2005) · Cited by 172
Pulmonary Function Testing in Idiopathic Interstitial Pneumonias
Martinez, F. J., & Flaherty, K. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-022tk · Cited by 169
“Another investigative group extended these observations by creating a composite score that included spirometric (FEV1 and FVC) and DlCO measurements (31).”
BackgroundInfluentialSeipin: from human disease to molecular mechanism
Cartwright, B. R., & Goodman, J. M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r023754 · Cited by 157
Non-steroid agents for idiopathic pulmonary fibrosis
Spagnolo, P., Del Giovane, C., Luppi, F., Cerri, S., Balduzzi, S., Walters, E. H., D'Amico, R., & Richeldi, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003134.pub2 · Cited by 163
Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression
Chien, J. W., Richards, T. J., Gibson, K. F., Zhang, Y., Lindell, K. O., Shao, L., Lyman, S. K., Adamkewicz, J. I., Smith, V., Kaminski, N., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00141013 · Cited by 156
Schmidt, S. L., Nambiar, A. M., Tayob, N., Sundaram, B., Han, M. K., Gross, B. H., Kazerooni, E. A., Chughtai, A. R., Lagstein, A., Myers, J. L., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00114010 · Cited by 160
Precision medicine advances in idiopathic pulmonary fibrosis
Karampitsakos, Τ., Juan-Guardela, B. M., Τzouvelekis, Α., & Herazo‐Maya, J. D. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104766 · Cited by 157
Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality
Edey, A., Devaraj, A., Barker, R. P., Nicholson, A. G., Wells, A. U., & Hansell, D. M. (2011) · European Radiology · doi:10.1007/s00330-011-2098-2 · Cited by 149
“honeycombing (comprising cystic airspaces measuring greater than 4 mm in diameter) [8, 17]; and (e) consolidation.”
BackgroundSelf-citationSmad3 Signaling Involved in Pulmonary Fibrosis and Emphysema
Gauldie, J., Kolb, M., Ask, K., Martin, G., Bonniaud, P., & Warburton, D. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-125sf · Cited by 145
“Although there are a number of other interleukins, growth factors and chemokines found in IPF tissue, TGF- appears the likely common element through which tissue damage results in tissue repair.”
BackgroundInfluentialProgression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease
Tcherakian, C., Cottin, V., Brillet, P.-Y., Freynet, O., Naggara, N., Carton, Z., Cordier, J.-F., Brauner, M., Valeyre, D., & Nunes, H. (2011) · Thorax · doi:10.1136/thx.2010.137190 · Cited by 144
Contractile Fatigue, Muscle Morphometry, and Blood Lactate in Chronic Obstructive Pulmonary Disease
Saey, D., Michaud, A., Couillard, A., Côté, C. H., Mador, M. J., LeBlanc, P., Jobin, J., & Maltais, F. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1005oc · Cited by 143
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
Huang, Y., Ma, S.-F., Espindola, M. S., Vij, R., Oldham, J. M., Huffnagle, G. B., Erb-Downward, J. R., Flaherty, K. R., Moore, B. B., White, E. S., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1525oc · Cited by 142
Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
Holland, A. E., Hill, C. J., Glaspole, I., Goh, N. S. L., & McDonald, C. F. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.11.014 · Cited by 152
Self-citationThe impact of emphysema in pulmonary fibrosis
Cottin, V. (2013) · European Respiratory Review · doi:10.1183/09059180.00000813 · Cited by 137
Fibrosis: cross-organ biology and pathways to development of innovative drugs
Rieder, F., Nagy, L. E., Maher, T. M., Distler, J. H. W., Kramann, R., Hinz, B., & Prunotto, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01158-9 · Cited by 151
“At baseline, both forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DL CO ) are predictive of prognosis 211 .”
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis
Akagi, T., Matsumoto, T., Harada, T., Tanaka, M., Kuraki, T., Fujita, M., & Watanabe, K. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.02.001 · Cited by 143
High Resolution Multidetector CT-Aided Tissue Analysis and Quantification of Lung Fibrosis
Zavaletta, V. A., Bartholmai, B. J., & Robb, R. A. (2007) · Academic Radiology · doi:10.1016/j.acra.2007.03.009 · Cited by 136
Kim, H. J., Brown, M. S., Chong, D. Y., Gjertson, D. W., Lu, P., Kim, H. J., Coy, H., & Goldin, J. G. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.08.004 · Cited by 143
Validation of the prognostic value of MMP‐7 in idiopathic pulmonary fibrosis
Tzouvelekis, A., Herazo‐Maya, J. D., Slade, M., Chu, J., Deiuliis, G., Ryu, C., Li, Q., Sakamoto, K., Ibarra, G., Pan, H., et al. (2017) · Respirology · doi:10.1111/resp.12920 · Cited by 130
Idiopathic Pulmonary Fibrosis: Evolving Concepts
Ryu, J. H., Moua, T., Daniels, C. E., Hartman, T. E., Yi, E. S., Utz, J. P., & LIMPER, A. H. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.03.016 · Cited by 143
Glaspole, I. N., Chapman, S. A., Cooper, W. A., Ellis, S. J., Goh, N. S., Hopkins, P. M., Macansh, S., Mahar, A., Moodley, Y. P., Paul, E., et al. (2017) · Respirology · doi:10.1111/resp.12989 · Cited by 123
Self-citationIdiopathic pulmonary fibrosis: An update
Spagnolo, P., Sverzellati, N., Rossi, G., Cavazza, A., Tzouvelekis, A., Crestani, B., & Vancheri, C. (2015) · Annals of Medicine · doi:10.3109/07853890.2014.982165 · Cited by 120
Saketkoo, L. A., Mittoo, S., Huscher, D., Khanna, D., Dellaripa, P. F., Distler, O., Flaherty, K. R., Frankel, S., Oddis, C. V., Denton, C. P., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204202 · Cited by 120
Self-citationFunctional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M. A., Maher, T. M., Nair, A., Karwoski, R. A., Renzoni, E. A., Walsh, S. L. F., Hansell, D. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00379-2017 · Cited by 127
Self-citationLung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification
Egan, J. J. (2005) · Thorax · doi:10.1136/thx.2004.035436 · Cited by 121
Self-citation
Metadata
- Authors
- Wells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M.
- Affiliations
- Mayo Clinic (US)
- Department of Radiology and Department of Physiology Royal Brompton Hospital, Interstitial Lung Disease Unit; Department of Radiology, King's College Hospital, London, United Kingdom; and Department of Pathology, Mayo Clinic, Scottsdale, Arizona
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 167
- Issue
- 7
- Pages
- 962-969
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3022958008
- Cited by
- 686
- References
- 32
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 28 · 2023: 39 · 2022: 37 · 2021: 48 · 2020: 42 · 2019: 40 · 2018: 40 · 2017: 52 · 2016: 47 · 2015: 42 · 2014: 27 · 2013: 38 · 2012: 22
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, usual interstitial pneumonia, composite physiologic index, pulmonary function tests, diffusing capacity for carbon monoxide, mortality prediction, prognostic score
- MeSH terms
- Aged, Biopsy, Carbon Monoxide, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Lung, Male, Middle Aged, Monitoring, Physiologic, Predictive Value of Tests, Prognosis, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Fibrosis, Statistics as Topic, Tomography, X-Ray Computed, Total Lung Capacity, Vital Capacity, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.